Sai Life Sciences Limited has informed the Exchange about Transcript for the Un-audited Financial Results for the quarter and nine months ended on 3 December 2025.
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has informed NSE and BSE that the transcript of its Q3 FY26 earnings call, held on 6 February 2026, has been uploaded on the company's website. The filing is a routine compliance disclosure under SEBI's Listing Regulations and does not itself contain financial figures. The actual transcript is available as a PDF on the company's website for shareholders and analysts to review.
This is a procedural filing with no direct impact on the stock. Investors seeking colour on margins, revenue, order book, or guidance from Q3 FY26 will need to read the attached transcript on the company's website.